Inflammatory Bowel Diseases

• Asan Medical Center — Seoul, South Korea

• Lynderm Research — Markham, Ontario, Canada
• Innovaderm Research Inc. — Montreal, Quebec, Canada
• Dr Isabelle Delorme — Saint-Hyacinthe, Quebec, Canada

• Cedars-Sinai IBD Center — Los Angeles, California, United States
• Connecticut Children's Medical Center — Hartford, Connecticut, United States
• Miami Research Associates — Miami, Florida, United States
• Johns Hopkins University School of Medicine — Baltimore, Maryland, United States

• Digestive Disease Associates — Gainesville, Florida, United States
• Borland Groover Clinic — Jacksonville, Florida, United States
• Atlanta Gastroenterology Associates — Atlanta, Georgia, United States
• University of Kentucky Medical Center — Lexington, Kentucky, United States

Not specified

• Elan Pharmaceuticals — San Diego, California, United States

• Performed only at CD251, CD301, CD303, CD306, and CD307 sites globally. No general public enrollment. The study is managed from the office of Elan Pharmaceuticals, Inc. in — San Diego, California, United States

• Asan Medical Center — Seoul, South Korea

• School of Medicine, University of Glasgow / New Lister Building, Glasgow Royal Infirmary — Glasgow, United Kingdom

• Internal Medicine Center, LLC — Mobile, Alabama, United States
• Springhill Memorial Hospital — Mobile, Alabama, United States
• Investigational Drug Service Pharmacy — La Jolla, California, United States
• UCSD Medical Center — La Jolla, California, United States